Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.49 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 11.89110.95613.01111.34310.2268.10917.79511.459.8998.7217.1599.53315.599169.41816.5963.733-0.2510.251
Short Term Investments 40.39847.12552.74660.6768.61487.39689.321105.108113.815127.503140.462147.129146.8990000.5020
Cash and Short Term Investments 52.28958.08165.75772.01378.848.10917.795116.558123.714136.224147.6219.53315.599169.41816.5963.7330.2510.251
Net Receivables 000000000000000000
Inventory 000000000000000000
Other Current Assets 1.6552.1531.4930.3180.2520.4540.3440.3360.2930.1990.3740.3010.4720.063.480.69600.251
Total Current Assets 53.94460.23467.2572.01381.06998.608108.589118.482127.491138.977148.542158.162165.613172.78520.0764.4290.2510.502
Non-Current Assets:
Property, Plant & Equipment, Net 5.7686.3757.0387.7368.4259.2449.72410.27610.511.0224.6443.062.1111.6551.2661.0500.268
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 000000000000000000
Tax Assets 000000000000000000
Other Non-Current Assets 0.0870.0860.0861.9090.0860.0810.0630.0450.0450.0390.0390.02700.0360.0860.036-0.2510.447
Total Non-Current Assets 5.8556.4617.1249.6458.5119.3259.78710.32110.54511.0614.6833.0872.1111.6911.3521.086-0.2510.715
Total Assets 59.79966.69574.37481.65889.58107.933118.375128.803138.036150.038153.225161.249167.724174.47621.4285.51501.217
Liabilities & Equity:
Current Liabilities:
Account Payables 1.64621.6942.7272.3294.7154.4734.6572.4235.12.4563.6142.8282.0023.8820.97403.451
Short Term Debt 2.4552.4782.4392.4062.3132.2852.1312.0731.9921.9460.680000.5672.489016.055
Tax Payables 000000000000000000
Deferred Revenue 000-2.727-2.329-4.715-4.4730-2.423-5.100000.3490.98102.083
Other Current Liabilities 0.8480.5141.513.823.0445.2986.9351.7623.4425.661.7531.651.0950.4730.0320.27100.125
Total Current Liabilities 4.9494.9925.6436.2265.3577.5839.0668.4925.4347.6064.8895.2643.9232.4754.834.715021.714
Non-Current Liabilities:
Long Term Debt 2.5913.1613.7694.3654.955.4665.9026.3256.6867.1241.6740.7770.5670.5670.5670.56700
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 0.0670.0680.0670.0670.0720.03400000.14900.1090.18272.47451.914048.165
Total Non-Current Liabilities 2.6583.2293.8364.4325.0225.55.9026.3256.6867.1241.8230.7770.6760.74973.04152.481048.165
Total Liabilities 7.6078.2219.47910.65810.37913.08314.96814.81712.1214.736.7126.0414.5993.22477.87157.196069.879
Equity:
Preferred Stock 00000000000161.2490174.47672.33651.78847.54547.545
Common Stock 0.0030.0030.0030.0020.0030.0030.0030.0030.0030.0030.0030.0030.0030.00300.00900
Retained Earnings -247.029-239.887-231.895-224.481-217.357-207.971-197.794-185.562-172.146-161.611-149.206-139.84-130.155-120.384-112.412-107.2810-92.312
Accumulated Other Comprehensive Income/Loss -0.093-0.137-0.209-0.402-0.549-0.823-1.004-1.205-1.212-0.899-0.333-0.069-0.101-174.4760-0.009-68.662-0.387
Other Total Stockholders Equity 299.311298.495296.996295.881297.104303.641302.202300.75299.271297.815296.049133.865293.378291.633-16.3673.8120-23.508
Total Shareholders Equity 52.19258.47464.8957179.20194.85103.407113.986125.916135.308146.513155.208163.125171.252-56.443-51.681-21.117-68.662
Total Equity 52.19258.47464.8957179.20194.85103.407113.986125.916135.308146.513155.208163.125171.252-56.443-51.681-21.117-68.662
Total Liabilities & Shareholders Equity 59.79966.69574.37481.65889.58107.933118.375128.803138.036150.038153.225161.249167.724174.47621.4285.515-21.1171.217